Safety and tolerability of different titration rates of retigabine (ezogabine) in patients with partial-onset seizures
Authors:
- Victor BitonVBVictor Biton
- Antonio Gil-NagelAGAntonio Gil-Nagel
- Martin J. BrodieMBMartin J. Brodie
- Sarah E. DeRossettSDSarah E. DeRossett
- Virinder NohriaVNVirinder Nohria
- 1 November 2013
- journal article
- research article
- Published by Elsevier in Epilepsy Research
- Vol. 107 (1-2) , 138-145
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline and Valeant Pharmaceuticals International
This publication has 20 references indexed in Scilit:
- Retigabine for the Adjunctive Treatment of Adults with Partial-Onset Seizures in Epilepsy with and without Secondary GeneralizationPharmacoEconomics, 2013
- The mechanism of action of retigabine (ezogabine), a first‐in‐class K+channel opener for the treatment of epilepsyEpilepsia, 2012
- Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsyNeurology, 2011
- Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsyNeurology, 2010
- Adverse effects of antiepileptic drugs: a brief overview of important issuesExpert Review of Neurotherapeutics, 2010
- Refinement of the Binding Site and Mode of Action of the Anticonvulsant Retigabine on KCNQ K+ ChannelsMolecular Pharmacology, 2009
- Ein- und Ausschleichen von AntiepileptikaTherapeutische Umschau, 2008
- N-Glucuronidation of the antiepileptic drug retigabine: results from studies with human volunteers, heterologously expressed human UGTs, human liver, kidney, and liver microsomal membranes of Crigler-Najjar type IIMetabolism, 2006
- Rapid initiation of gabapentinNeurology, 2001
- Topiramate Titration and TolerabilityAnnals of Pharmacotherapy, 2001